NKGen Biotech Ownership 2024 | Who Owns NKGen Biotech Now?

OverviewFinancials Chart

Institutional Ownership

31.65%

Insider Ownership

41.42%

Retail Ownership

26.92%

Institutional Holders

13.00

NKGen Biotech Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
JPMORGAN CHASE & CO	-	-	-	-100,557	-100.00%	-	Dec 31, 2023
KARPUS MANAGEMENT, INC.	-	-	-	-280,525	-100.00%	-	Dec 31, 2023
BALYASNY ASSET MANAGEMENT L.P.	-	-	-	-310,359	-100.00%	-	Dec 31, 2023
RIVERNORTH CAPITAL MANAGEMENT, LLC	-	-	-	-580,432	-100.00%	-	Dec 31, 2023
ALBERTA INVESTMENT MANAGEMENT CORP	-	-	-	-200,000	-100.00%	-	Dec 31, 2023
WESTCHESTER CAPITAL MANAGEMENT, LLC	-	-	-	-105,266	-100.00%	-	Dec 31, 2023
MINT TOWER CAPITAL MANAGEMENT B.V.	-	-	-	-200,000	-100.00%	-	Dec 31, 2023
PERISCOPE CAPITAL INC.	-	-	-	-347,994	-100.00%	-	Dec 31, 2023
CLEAR STREET LLC	-	-	-	-73,364	-100.00%	-	Dec 31, 2023
DIAMETRIC CAPITAL, LP	-	-	-	-471,000	-100.00%	-	Dec 31, 2023
SANDIA INVESTMENT MANAGEMENT LP	-	-	-	-471,000	-100.00%	-	Dec 31, 2023
METEORA CAPITAL, LLC	-	-	-	-2,122,715	-100.00%	-	Dec 31, 2023
SPARTAN FUND MANAGEMENT INC.	-	-	-	-62,987	-100.00%	-	Dec 31, 2023

NKGen Biotech's largest institutional shareholder is JPMORGAN CHASE & CO, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
JPMORGAN CHASE & CO	-	-	-	-100,557	-100.00%	-	Dec 31, 2023
KARPUS MANAGEMENT, INC.	-	-	-	-280,525	-100.00%	-	Dec 31, 2023
BALYASNY ASSET MANAGEMENT L.P.	-	-	-	-310,359	-100.00%	-	Dec 31, 2023
RIVERNORTH CAPITAL MANAGEMENT, LLC	-	-	-	-580,432	-100.00%	-	Dec 31, 2023
ALBERTA INVESTMENT MANAGEMENT CORP	-	-	-	-200,000	-100.00%	-	Dec 31, 2023
WESTCHESTER CAPITAL MANAGEMENT, LLC	-	-	-	-105,266	-100.00%	-	Dec 31, 2023
MINT TOWER CAPITAL MANAGEMENT B.V.	-	-	-	-200,000	-100.00%	-	Dec 31, 2023
PERISCOPE CAPITAL INC.	-	-	-	-347,994	-100.00%	-	Dec 31, 2023
CLEAR STREET LLC	-	-	-	-73,364	-100.00%	-	Dec 31, 2023
DIAMETRIC CAPITAL, LP	-	-	-	-471,000	-100.00%	-	Dec 31, 2023
SANDIA INVESTMENT MANAGEMENT LP	-	-	-	-471,000	-100.00%	-	Dec 31, 2023
METEORA CAPITAL, LLC	-	-	-	-2,122,715	-100.00%	-	Dec 31, 2023
SPARTAN FUND MANAGEMENT INC.	-	-	-	-62,987	-100.00%	-	Dec 31, 2023

The largest NKGen Biotech shareholder by % of total assets is JPMORGAN CHASE & CO. The company owns 0.00 shares of NKGen Biotech (GFOR), representing 0.00% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
SPARTAN FUND MANAGEMENT INC.	-	-	-	-62,987	-100.00%	-	Dec 31, 2023
CLEAR STREET LLC	-	-	-	-73,364	-100.00%	-	Dec 31, 2023
JPMORGAN CHASE & CO	-	-	-	-100,557	-100.00%	-	Dec 31, 2023
WESTCHESTER CAPITAL MANAGEMENT, LLC	-	-	-	-105,266	-100.00%	-	Dec 31, 2023
MINT TOWER CAPITAL MANAGEMENT B.V.	-	-	-	-200,000	-100.00%	-	Dec 31, 2023
ALBERTA INVESTMENT MANAGEMENT CORP	-	-	-	-200,000	-100.00%	-	Dec 31, 2023
KARPUS MANAGEMENT, INC.	-	-	-	-280,525	-100.00%	-	Dec 31, 2023
BALYASNY ASSET MANAGEMENT L.P.	-	-	-	-310,359	-100.00%	-	Dec 31, 2023
PERISCOPE CAPITAL INC.	-	-	-	-347,994	-100.00%	-	Dec 31, 2023
SANDIA INVESTMENT MANAGEMENT LP	-	-	-	-471,000	-100.00%	-	Dec 31, 2023
DIAMETRIC CAPITAL, LP	-	-	-	-471,000	-100.00%	-	Dec 31, 2023
RIVERNORTH CAPITAL MANAGEMENT, LLC	-	-	-	-580,432	-100.00%	-	Dec 31, 2023
METEORA CAPITAL, LLC	-	-	-	-2,122,715	-100.00%	-	Dec 31, 2023

As of Dec 31 2023, NKGen Biotech's largest institutional buyer is SPARTAN FUND MANAGEMENT INC.. The company purchased -62.99K stocks of GFOR, valued at -.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
METEORA CAPITAL, LLC	-	-	-	-2,122,715	-100.00%	-	Dec 31, 2023
RIVERNORTH CAPITAL MANAGEMENT, LLC	-	-	-	-580,432	-100.00%	-	Dec 31, 2023
DIAMETRIC CAPITAL, LP	-	-	-	-471,000	-100.00%	-	Dec 31, 2023
SANDIA INVESTMENT MANAGEMENT LP	-	-	-	-471,000	-100.00%	-	Dec 31, 2023
PERISCOPE CAPITAL INC.	-	-	-	-347,994	-100.00%	-	Dec 31, 2023
BALYASNY ASSET MANAGEMENT L.P.	-	-	-	-310,359	-100.00%	-	Dec 31, 2023
KARPUS MANAGEMENT, INC.	-	-	-	-280,525	-100.00%	-	Dec 31, 2023
ALBERTA INVESTMENT MANAGEMENT CORP	-	-	-	-200,000	-100.00%	-	Dec 31, 2023
MINT TOWER CAPITAL MANAGEMENT B.V.	-	-	-	-200,000	-100.00%	-	Dec 31, 2023
WESTCHESTER CAPITAL MANAGEMENT, LLC	-	-	-	-105,266	-100.00%	-	Dec 31, 2023
JPMORGAN CHASE & CO	-	-	-	-100,557	-100.00%	-	Dec 31, 2023
CLEAR STREET LLC	-	-	-	-73,364	-100.00%	-	Dec 31, 2023
SPARTAN FUND MANAGEMENT INC.	-	-	-	-62,987	-100.00%	-	Dec 31, 2023

As of Dec 31 2023, NKGen Biotech's biggest institutional seller is METEORA CAPITAL, LLC. The company sold -2.12M shares of GFOR, valued at -.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
METEORA CAPITAL, LLC	-	-	-	-2,122,715	-100.00%	-	Dec 31, 2023
RIVERNORTH CAPITAL MANAGEMENT, LLC	-	-	-	-580,432	-100.00%	-	Dec 31, 2023
DIAMETRIC CAPITAL, LP	-	-	-	-471,000	-100.00%	-	Dec 31, 2023
SANDIA INVESTMENT MANAGEMENT LP	-	-	-	-471,000	-100.00%	-	Dec 31, 2023
PERISCOPE CAPITAL INC.	-	-	-	-347,994	-100.00%	-	Dec 31, 2023
BALYASNY ASSET MANAGEMENT L.P.	-	-	-	-310,359	-100.00%	-	Dec 31, 2023
KARPUS MANAGEMENT, INC.	-	-	-	-280,525	-100.00%	-	Dec 31, 2023
ALBERTA INVESTMENT MANAGEMENT CORP	-	-	-	-200,000	-100.00%	-	Dec 31, 2023
MINT TOWER CAPITAL MANAGEMENT B.V.	-	-	-	-200,000	-100.00%	-	Dec 31, 2023
WESTCHESTER CAPITAL MANAGEMENT, LLC	-	-	-	-105,266	-100.00%	-	Dec 31, 2023
JPMORGAN CHASE & CO	-	-	-	-100,557	-100.00%	-	Dec 31, 2023
CLEAR STREET LLC	-	-	-	-73,364	-100.00%	-	Dec 31, 2023
SPARTAN FUND MANAGEMENT INC.	-	-	-	-62,987	-100.00%	-	Dec 31, 2023

NKGen Biotech's largest sold out institutional shareholder by shares sold is METEORA CAPITAL, LLC, sold -2.12M shares, valued at -, as of undefined.

NKGen Biotech Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
SPECIAL OPPORTUNITIES FUND, INC.	0.20%	100,000	-	-	Dec 31, 2023
GABELLI DIVIDEND & INCOME TRUST	0.08%	135,000	-	-	Dec 29, 2023
RIVERNORTH OPPORTUNITIES FUND, INC.	0.04%	48,320	-	-	Jan 31, 2024
RiverNorth Specialty Finance Corp	0.02%	22,295	22,295	-	Sep 30, 2023
Listed Funds Trust	0.02%	10,502	-	-	Feb 29, 2024
Saba Capital Income & Opportunities Fund	0.02%	55,750	-	-	Jan 31, 2024
SCM Trust	0.02%	65,772	-	-	Dec 31, 2023
MERGER FUND	0.01%	85,305	-	-	Dec 29, 2023
MERGER FUND VL	0.01%	1,034	-	-	Dec 29, 2023
Virtus Event Opportunities Trust	0.00%	9,192	-	-	Dec 29, 2023
FIRST TRUST ALTERNATIVE OPPORTUNITIES FUND	0.00%	2,885	-	-	Dec 31, 2023
VANGUARD INDEX FUNDS	0.00%	3,572	3,572	-	Dec 31, 2023
PRINCIPAL FUNDS, INC.	0.00%	1,561	-	-	Feb 29, 2024

NKGen Biotech's largest mutual fund holder by % of total assets is "SPECIAL OPPORTUNITIES FUND, INC.", owning 100.00K shares, compromising 0.20% of its total assets.

NKGen Biotech Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
30 Sep, 23	13	-48.00%
30 Jun, 23	25	-53.70%
31 Mar, 23	54	-10.00%
31 Dec, 22	60	17.65%
30 Sep, 22	51	8.51%
30 Jun, 22	47	11.90%
31 Mar, 22	42	5.00%
31 Dec, 21	40	11.11%
30 Sep, 21	36	-

As of 30 Sep 23, 13 institutions are holding NKGen Biotech's shares, representing a decrease of -48.00% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
30 Sep, 23	5,326,199	-12.66%
30 Jun, 23	6,098,503	-62.35%
31 Mar, 23	16,198,501	1.86%
31 Dec, 22	15,903,027	8.91%
30 Sep, 22	14,602,549	15.57%
30 Jun, 22	12,635,460	3.44%
31 Mar, 22	12,215,582	10.17%
31 Dec, 21	11,087,449	17.84%
30 Sep, 21	9,409,113	-

NKGen Biotech (GFOR) has 5.33M shares outstanding as of 30 Sep 23, down -12.66% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
30 Sep, 23	31.65%	3.92%
30 Jun, 23	28.43%	0.50%
31 Mar, 23	75.51%	1.37%
31 Dec, 22	74.13%	1.60%
30 Sep, 22	68.07%	1.96%
30 Jun, 22	58.90%	1.82%
31 Mar, 22	56.94%	2.13%
31 Dec, 21	51.69%	2.69%
30 Sep, 21	43.86%	-

As of 30 Sep 23, NKGen Biotech is held by 31.65% institutional shareholders, representing a 3.92% growth compared to 30 Jun 23.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
30 Sep, 23	4	-50.00%
30 Jun, 23	8	-38.46%
31 Mar, 23	13	-55.17%
31 Dec, 22	29	81.25%
30 Sep, 22	16	33.33%
30 Jun, 22	12	-
31 Mar, 22	12	-7.69%
31 Dec, 21	13	-63.89%
30 Sep, 21	36	-

4 institutional shareholders have increased their position in GFOR stock as of 30 Sep 23 compared to 8 in the previous quarter (a -50.00% decrease).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
30 Sep, 23	3	-72.73%
30 Jun, 23	11	37.50%
31 Mar, 23	8	33.33%
31 Dec, 22	6	-25.00%
30 Sep, 22	8	700.00%
30 Jun, 22	1	-66.67%
31 Mar, 22	3	-40.00%
31 Dec, 21	5	-
30 Sep, 21	-	-

3 institutional shareholders have reduced their position in GFOR stock as of 30 Sep 23 compared to 11 in the previous quarter (a -72.73% decrease).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
30 Sep, 23	13	-48.00%	5,326,199	-12.66%	31.65%	3.92%	4	-50.00%	3	-72.73%
30 Jun, 23	25	-53.70%	6,098,503	-62.35%	28.43%	0.50%	8	-38.46%	11	37.50%
31 Mar, 23	54	-10.00%	16,198,501	1.86%	75.51%	1.37%	13	-55.17%	8	33.33%
31 Dec, 22	60	17.65%	15,903,027	8.91%	74.13%	1.60%	29	81.25%	6	-25.00%
30 Sep, 22	51	8.51%	14,602,549	15.57%	68.07%	1.96%	16	33.33%	8	700.00%
30 Jun, 22	47	11.90%	12,635,460	3.44%	58.90%	1.82%	12	-	1	-66.67%
31 Mar, 22	42	5.00%	12,215,582	10.17%	56.94%	2.13%	12	-7.69%	3	-40.00%
31 Dec, 21	40	11.11%	11,087,449	17.84%	51.69%	2.69%	13	-63.89%	5	-
30 Sep, 21	36	-	9,409,113	-	43.86%	-	36	-	-	-

NKGen Biotech Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Dec 07, 2023	Song Paul Y.	director, officer	Chief Executive Officer	P-Purchase	Buy	76	$3.29	$250.24	171,120
Dec 07, 2023	Song Paul Y.	director, officer	Chief Executive Officer	P-Purchase	Buy	75	$3.32	$250.00	171,044
Dec 05, 2023	Song Paul Y.	director, officer	Chief Executive Officer	P-Purchase	Buy	105	$3.33	$350.22	170,969
Dec 05, 2023	Song Paul Y.	director, officer	Chief Executive Officer	P-Purchase	Buy	162	$3.07	$499.73	170,864
Dec 05, 2023	Graf James A	officer	Interim CFO	P-Purchase	Buy	450	$3.19	$1.44K	693
Dec 05, 2023	Graf James A	officer	Interim CFO	P-Purchase	Buy	220	$3.35	$737.00	243
Nov 28, 2023	Song Paul Y.	director, officer	Chief Executive Officer	P-Purchase	Buy	140	$2.85	$400.14	170,701
Nov 28, 2023	Song Paul Y.	director, officer	Chief Executive Officer	P-Purchase	Buy	103	$2.91	$300.46	170,560
Nov 22, 2023	Graf James A	officer	Interim CFO	P-Purchase	Buy	13	$2.92	$37.90	23
Nov 22, 2023	Graf James A	officer	Interim CFO	P-Purchase	Buy	10	$2.94	$29.40	10
Nov 22, 2023	Song Paul Y.	director, officer	Chief Executive Officer	P-Purchase	Buy	52	$2.85	$150.00	170,457
Nov 22, 2023	Song Paul Y.	director, officer	Chief Executive Officer	P-Purchase	Buy	100	$2.80	$280.00	170,405

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Dec 07, 2023	Song Paul Y.	director, officer	Chief Executive Officer	P-Purchase	Buy	76	$3.29	$250.24	171,120
Dec 07, 2023	Song Paul Y.	director, officer	Chief Executive Officer	P-Purchase	Buy	75	$3.32	$250.00	171,044
Dec 05, 2023	Song Paul Y.	director, officer	Chief Executive Officer	P-Purchase	Buy	105	$3.33	$350.22	170,969
Dec 05, 2023	Song Paul Y.	director, officer	Chief Executive Officer	P-Purchase	Buy	162	$3.07	$499.73	170,864
Dec 05, 2023	Graf James A	officer	Interim CFO	P-Purchase	Buy	450	$3.19	$1.44K	693
Dec 05, 2023	Graf James A	officer	Interim CFO	P-Purchase	Buy	220	$3.35	$737.00	243
Nov 28, 2023	Song Paul Y.	director, officer	Chief Executive Officer	P-Purchase	Buy	140	$2.85	$400.14	170,701
Nov 28, 2023	Song Paul Y.	director, officer	Chief Executive Officer	P-Purchase	Buy	103	$2.91	$300.46	170,560
Nov 22, 2023	Graf James A	officer	Interim CFO	P-Purchase	Buy	13	$2.92	$37.90	23
Nov 22, 2023	Graf James A	officer	Interim CFO	P-Purchase	Buy	10	$2.94	$29.40	10
Nov 22, 2023	Song Paul Y.	director, officer	Chief Executive Officer	P-Purchase	Buy	52	$2.85	$150.00	170,457
Nov 22, 2023	Song Paul Y.	director, officer	Chief Executive Officer	P-Purchase	Buy	100	$2.80	$280.00	170,405

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Dec 15, 2023	Park Sangwoo	director, 10 percent owner		G-Gift	Sell	2,500,000	-	-	10,120,612
Oct 10, 2023	Gagnon Pierre	officer	Chief Operating Officer		Sell	11,353	$0.32	$3.63K	-
Oct 10, 2023	Gagnon Pierre	officer	Chief Operating Officer		Sell	150,481	$6.67	$1.00M	-
Oct 10, 2023	Kim Yong Man	officer	CSO and CIO		Sell	-	-	-	28,384
Oct 10, 2023	Kim Yong Man	officer	CSO and CIO		Sell	133,450	$6.67	$890.11K	-

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Dec 15, 2023	Park Sangwoo	director, 10 percent owner		G-Gift	Sell	2,500,000	-	-	10,120,612
Dec 07, 2023	Song Paul Y.	director, officer	Chief Executive Officer	P-Purchase	Buy	76	$3.29	$250.24	171,120
Dec 07, 2023	Song Paul Y.	director, officer	Chief Executive Officer	P-Purchase	Buy	75	$3.32	$250.00	171,044
Dec 05, 2023	Song Paul Y.	director, officer	Chief Executive Officer	P-Purchase	Buy	105	$3.33	$350.22	170,969
Dec 05, 2023	Song Paul Y.	director, officer	Chief Executive Officer	P-Purchase	Buy	162	$3.07	$499.73	170,864
Dec 05, 2023	Graf James A	officer	Interim CFO	P-Purchase	Buy	450	$3.19	$1.44K	693
Dec 05, 2023	Graf James A	officer	Interim CFO	P-Purchase	Buy	220	$3.35	$737.00	243
Nov 28, 2023	Song Paul Y.	director, officer	Chief Executive Officer	P-Purchase	Buy	140	$2.85	$400.14	170,701
Nov 28, 2023	Song Paul Y.	director, officer	Chief Executive Officer	P-Purchase	Buy	103	$2.91	$300.46	170,560
Nov 22, 2023	Graf James A	officer	Interim CFO	P-Purchase	Buy	13	$2.92	$37.90	23
Nov 22, 2023	Graf James A	officer	Interim CFO	P-Purchase	Buy	10	$2.94	$29.40	10
Nov 22, 2023	Song Paul Y.	director, officer	Chief Executive Officer	P-Purchase	Buy	52	$2.85	$150.00	170,457
Nov 22, 2023	Song Paul Y.	director, officer	Chief Executive Officer	P-Purchase	Buy	100	$2.80	$280.00	170,405
Oct 10, 2023	Klowden Michael	director			Buy	-	-	-	-
Oct 10, 2023	Scott Kathleen D.	director			Buy	-	-	-	-
Oct 10, 2023	McNulty Alana B.	director			Buy	-	-	-	-
Oct 10, 2023	Gagnon Pierre	officer	Chief Operating Officer		Sell	11,353	$0.32	$3.63K	-
Oct 10, 2023	Gagnon Pierre	officer	Chief Operating Officer		Sell	150,481	$6.67	$1.00M	-
Oct 10, 2023	Kim Yong Man	officer	CSO and CIO		Sell	-	-	-	28,384
Oct 10, 2023	Kim Yong Man	officer	CSO and CIO		Sell	133,450	$6.67	$890.11K	-

The last insider sell of NKGen Biotech's stock was made by Park Sangwoo on Dec 15 2023, selling 2,500,000 shares at - per share (valued at -). The last insider buy of GFOR was made by Song Paul Y. on Dec 07 2023, buying 76 shares at $3.29 per share (worth $250.24).

NKGen Biotech Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q4 2023	12	1	1200.00%
Q3 2023	2	8	25.00%
Q2 2022	-	-	-
Q3 2021	-	2	-
Q2 2021	10	5	200.00%

12 total buy trades, and 1 total sell trades (buy/sell ratio of 12.00%) were made by NKGen Biotech's insiders, as of Q4 2023.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q4 2023	12	-	-
Q3 2023	-	-	-
Q2 2022	-	-	-
Q3 2021	-	-	-
Q2 2021	10	-	-

As of Q4 2023, Insider owners conducted 12 open market buy trades and 0 open market sell trades of NKGen Biotech's stocks.

NKGen Biotech Peer Ownership

Ticker	Company
ERES	Abacus Life, Inc.
VMCA	Valuence Merger Corp. I
LCAA	L Catterton Asia Acquisition Corp
DHAC	Digital Health Acquisition Corp.
FXCO	Financial Strategies Acquisition Corp.

GFOR Ownership FAQ

Who Owns NKGen Biotech?

NKGen Biotech is owned by institutional shareholders (31.65%), insiders (41.42%), and public (26.92%). The largest institutional shareholder of NKGen Biotech is JPMORGAN CHASE & CO (0% of total shares) and the top mutual fund owner is SPECIAL OPPORTUNITIES FUND, INC. (0.20% of total shares).

Who are the major institutional shareholders of NKGen Biotech?

NKGen Biotech's major institutional shareholders are JPMORGAN CHASE & CO, KARPUS MANAGEMENT, INC., BALYASNY ASSET MANAGEMENT L.P., RIVERNORTH CAPITAL MANAGEMENT, LLC, and ALBERTA INVESTMENT MANAGEMENT CORP. The top five shareholders own together 0% of the company's share outstanding.

How many NKGen Biotech shareholders are there?

As of Sep 2023, there are 13 institutional shareholders of NKGen Biotech.

What percentage of NKGen Biotech is owned by JPMORGAN CHASE & CO?

JPMORGAN CHASE & CO owns 0 shares of NKGen Biotech, representing 0% of the company's total shares outstanding, valued at $0 (as of Dec 2023).

What percentage of NKGen Biotech is owned by KARPUS MANAGEMENT, INC?

As of Dec 2023, KARPUS MANAGEMENT, INC holds 0 shares of NKGen Biotech (GFOR), compromising 0% of the company, valued at $0.

What percentage of NKGen Biotech is owned by BALYASNY ASSET MANAGEMENT L.P?

BALYASNY ASSET MANAGEMENT L.P is the third largest holder of NKGen Biotech. The company owns 0 of the company's shares outstanding (worth $0).